Psychoactive Drugs Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Psychoactive Drugs stocks.

Psychoactive Drugs Stocks Recent News

Date Stock Title
May 1 AZN AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases
May 1 FLGC Flora Growth Corp. Applauds Reported Historic DEA Move to Reschedule Cannabis
May 1 IMCC IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET
May 1 AVDL Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8
May 1 AZN AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio
Apr 30 AZN Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
Apr 30 AZN AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript
Apr 30 AQST Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for
Apr 29 AZN AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown
Apr 29 AQST Aquestive stock falls amid Libervant approval, Anaphylm update
Apr 29 CMPS Psychedelic drug developers could benefit from NIH funding for chronic pain
Apr 29 CLVR Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Apr 29 FLGC Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Apr 29 AZN AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Apr 29 AZN AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement
Apr 29 AVDL Wall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should Know
Apr 29 AZN AstraZeneca's Enhertu buoyed by progression-free survival data in breast cancer
Apr 29 AZN AstraZeneca, Daiichi look to broaden Enhertu use again with new study data
Apr 29 AZN ENHERTU® (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow
Apr 29 AQST Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film
Psychoactive Drugs

A psychoactive drug, psychopharmaceutical, or psychotropic is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition, or behavior. These substances may be used medically; recreationally; to purposefully improve performance or alter one's consciousness; as entheogens; for ritual, spiritual, or shamanic purposes; or for research. Some categories of psychoactive drugs, which have therapeutic value, are prescribed by physicians and other healthcare practitioners. Examples include anesthetics, analgesics, anticonvulsant and antiparkinsonian drugs as well as medications used to treat neuropsychiatric disorders, such as antidepressants, anxiolytics, antipsychotics, and stimulant medications. Some psychoactive substances may be used in the detoxification and rehabilitation programs for persons dependent on or addicted to other psychoactive drugs.
Psychoactive substances often bring about subjective (although these may be objectively observed) changes in consciousness and mood that the user may find rewarding and pleasant (e.g., euphoria or a sense of relaxation) or advantageous (e.g. increased alertness) and are thus reinforcing. Substances which are both rewarding and positively reinforcing have the potential to induce a state of addiction – compulsive drug use despite negative consequences. In addition, sustained use of some substances may produce physical or psychological dependence or both, associated with somatic or psychological-emotional withdrawal states respectively. Drug rehabilitation attempts to reduce addiction, through a combination of psychotherapy, support groups, and other psychoactive substances. Conversely, certain psychoactive drugs may be so unpleasant that the person will never use the substance again. This is especially true of certain deliriants (e.g. Jimson weed), powerful dissociatives (e.g. Salvia divinorum), and classic psychedelics (e.g. LSD, psilocybin), in the form of a "bad trip".
Psychoactive drug misuse, dependence and addiction have resulted in legal measures and moral debate. Governmental controls on manufacture, supply and prescription attempt to reduce problematic medical drug use. Ethical concerns have also been raised about over-use of these drugs clinically, and about their marketing by manufacturers. Popular campaigns to allow certain recreational drug use (e.g. cannabis) are also ongoing.

Browse All Tags